New Considerations in the Design of Clinical Trials for Bone Metastases

Abstract

Palliative radiotherapy (RT) is prescribed to patients with bone me-tastases to alleviate symptoms and improve quality of life. The lack of consistent endpoints for such trials has made cross study comparison difficult and has led to contradictory conclusions. The International Bone Metastases Consensus Working Party was established to create a standard set of endpoints and recommendations for future clinical trials. Recommendations were included regarding eligibility criteria, pain assessments, follow-up assessments, timing, as well as radiation techniques. Suggestions were also made to facilitate the ease with which different studies could be compared as well as to encourage widespread consistency in certain aspects of trial design. Investigators conducting clinical trials in bone me-tastases should continue to adopt these recommendations to ensure consistent guidelines based on the most recent literature.